ISMRM Workshops: Learn, Share Research & Network

ISMRM Workshop on

Cancer Imaging: From Discovery to Diagnosis

01-04 November 2020 • Bahia Resort Hotel, San Diego, CA, USA

Call for Abstracts & Stipend Applications
Submission Deadline: 08 September 2020 @ 23:59 EDT

Organizers

Co-Chair: Sungheon Gene Kim, Ph.D.
New York University School of Medicine, New York, NY, USA

Co-Chair: C. Chad Quarles, Ph.D.
Barrow Neurological Institute, Phoenix, AZ, USA

Registration & Travel

Registration Coming Soon
Early Registration Deadline:
29 September 2020

Travel Information

Supporters & Declarations

Faculty Declarations Coming August 2020

Overview & Program

Workshop Overview

This workshop, organized by the ISMRM MR of Cancer Working Group, will focus on the development and application of novel MRI/MRS acquisition and analysis technologies for cancer. At this bi-annual workshop, we will address and highlight strategies for successfully traversing the translational pipeline. Topics will include development and validation of new cancer imaging methods, analysis tools and probes, preclinical application, first-in-human studies, image-guided therapies, clinical trial evaluation, quality assurance and benchmarking, and clinical best practices.

The program will feature invited scientific presentations from a diverse group of experts in technical innovation and clinical practice (physicians and SMRT members), in addition to proffered papers and poster sessions. The Bill Negendank Young Investigator Awards, for which students, trainees, and post-doctoral fellows are eligible, will also be awarded based on the quality of the presented work.

Target Audience: The workshop is designed for basic scientists, physicians, regulators, technologists, students, trainees, and postdoctoral fellows with an interest in cancer MRI/MRS.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Describe novel cancer imaging methods and contrast mechanisms;
  • Describe advancements in clinical biomarker development;
  • Identify opportunities for image-guided adaptive therapy;
  • Recognize the role and challenges of using machine learning, artificial intelligence and mathematical modeling in cancer imaging applications;
  • Explain the role of quality assurance, standardization and benchmarking in clinical cancer imaging; and
  • Identify best practices for translation of cancer imaging methods into the clinic.

Preliminary Program

Registration & Setup – Monday, 01 November 2020 – No CME Available
16:00 Registration & Speaker Upload Available (until 20:00)
19:00 Opening Reception
Day 1 – Tuesday, 02 November 2020 – No CME Available
07:30 Registration & Speaker Upload Available
Breakfast on Own
08:20 Welcome & Opening Statements C. Chad Quarles, Ph.D.
Barrow Neurological Institute
Phoenix, AZ, USA
Session 1: Emerging Cancer Imaging Methods & Probes: Preclinical Validation
Moderators: T.B.A.
08:30 T.B.A. Kristine Glunde, Ph.D.
Johns Hopkins University
Baltimore, MD, USA
09:00 T.B.A. Kejia Cai, Ph.D.
University of Illinois at Chicago
Chicago, IL, USA

Proffered Papers - Oral Session

09:15 T.B.A.  
09:30 T.B.A.  
09:45 T.B.A.  
10:00 Break & Speaker Upload Available
Session 2: Emerging Cancer Imaging Methods & Probes: First-in-Human Studies
Moderators: T.B.A.
10:30 T.B.A. Ferdia A. Gallagher, Ph.D., MRCP, FRCR
University of Cambridge
Cambridge, England, UK
11:00 T.B.A. Hye Young Heo, Ph.D.
Johns Hopkins University
Baltimore, MD, USA

Proffered Papers - Oral Session

11:15 T.B.A.  
11:30 T.B.A.  
11:45 T.B.A.  
12:00 Lunch & Speaker Upload Available
Session 3: Clinical Applications of Cancer Imaging: Early Detection, Stratification, Genotyping & Phenotyping
Moderators: T.B.A.
13:30 T.B.A. Radka Stoyanova, Ph.D.
University of Miami
Miami, FL, USA
14:00 T.B.A. Ovidiu Andronesi, M.D., Ph.D.
Massachusetts General Hospital
Charlestown, MA , USA

Proffered Papers - Oral Session

14:15 T.B.A.  
14:30 T.B.A.  
14:45 T.B.A.  
15:00 Break & Speaker Upload Available
Session 4: Pathways for Clinical Translation: Clinical Best Practices
Moderators: T.B.A.
15:30 T.B.A. T.B.A.

 

15:45 T.B.A. T.B.A.

 

16:00 T.B.A. T.B.A.

 

16:15 T.B.A. T.B.A.

 

Session 5: Power Pitch & Poster Session
Moderators: T.B.A.

Power Pitch Session (No CME Available)

16:30 T.B.A.  
T.B.A.  
T.B.A.  

17:00 Poster Viewing Session (No CME Available)
Drinks
18:00 Adjournment
19:00 Dinner on Own
Day 2 – Wednesday, 03 November 2020 – No CME Available
07:30 Registration & Speaker Upload Available
Breakfast on Own
08:00 The Negendank Lecture Sabrina Ronen, Ph.D.
University of California, San Francisco
San Francisco, CA, USA
Session 6: Preclinical Applications: Novel Therapeutic Paradigms
Moderators: T.B.A.
08:45 T.B.A. Michal Neeman, Ph.D.
Weizmann Institute of Science
Rehovot, Israel
09:15 T.B.A. Kavindra Nath, Ph.D.
University of Pennsylvania
Philadelphia, PA, USA

Proffered Papers - Oral Session

09:30 T.B.A.  
09:45 T.B.A.  
10:00 T.B.A.  
10:15 Break & Speaker Upload Available
Session 7: Power Pitch & Poster Session
Moderators: T.B.A.

Power Pitch Session (No CME Available)

10:45 T.B.A.  
T.B.A.  
T.B.A.  

11:15 Poster Viewing Session (No CME Available)
12:15 Lunch & Speaker Upload Available
Session 8: Clinical Applications of Cancer Imaging: Biomarkers for Predicting & Monitoring Therapy Response
Moderators: T.B.A.
13:45 T.B.A. T.B.A.

 

14:15 T.B.A. Viola Rieke, Ph.D.
University of Utah
Salt Lake City, UT, USA

Proffered Papers - Oral Session

14:30 T.B.A.  
14:45 T.B.A.  
15:00 T.B.A.  
15:15 Break & Speaker Upload Available
Session 9: Clinical Applications of Cancer Imaging: Image-Guided & Adaptive Therapy
Moderators: T.B.A.
15:45 T.B.A. Paul Keall, Ph.D.
University of Sydney
Sydney, NSW, Australia
16:15 T.B.A. Saumya Gurbani, Ph.D.
Emory University
Atlanta, GA, USA

Proffered Papers - Oral Session

16:30 T.B.A.  
16:45 T.B.A.  
17:00 T.B.A.  
17:15 Adjournment
Dinner on Own
Day 3 – Thursday, 04 November 2020 – No CME Available
07:30 Registration & Speaker Upload Available
Breakfast on Own
Session 10: Cancer Image Analysis: Omics, Mathematical Modeling & Deep Learning
Moderators: T.B.A.
08:00 T.B.A. MaryEllen Giger, Ph.D.
University of Chicago
Chicago, IL, USA
08:30 T.B.A. Thomas Yankeelov, Ph.D.
University of Texas at Austin
Austin, TX, USA
09:00 T.B.A. T.B.A.

 

Proffered Papers - Oral Session

09:15 T.B.A.  
09:30 T.B.A.  
09:45 T.B.A.  
10:00 Break & Speaker Upload Available
Session 11: Pathways for Clinical Translation: Quality Assurance & Benchmarking
Moderators: T.B.A.
10:30 T.B.A. Amita Shukla-Dave, Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY, USA
11:00 T.B.A. Kathryn Keenan, Ph.D.
National Institute of Standards & Technology
Boulder, CO, USA

Proffered Papers - Oral Session

11:15 T.B.A.  
11:30 T.B.A.  
11:45 T.B.A.  
12:00 Boxed Lunches & Adjournment

Back Questions? Contact us at info@ismrm.org.

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.